Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hybridization of Imidazole with Various Heterocycles in Targeting Cancer: A Decade's Work
Ghanshyam Teli, Pooja A. Chawla
ChemistrySelect (2021) Vol. 6, Iss. 19, pp. 4803-4836
Closed Access | Times Cited: 21

Showing 21 citing articles:

Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 29
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship
Pronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116535-116535
Closed Access | Times Cited: 6
Enhanced Anticancer Selectivity of Cyclometalated Imidazole/Pyrazole-Imine IridiumIII Complexes Through the Switch from Cationic to Zwitterionic Forms
Zhe Liu, Kangning Lai, Pengwei Li, et al.
Inorganic Chemistry (2025)
Closed Access
Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)
Lian‐Shun Feng, Wen‐Qi Su, Jin‐Bo Cheng, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 34
Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents
Fayza O. Ashmawy, Sobhi M. Gomha, Magda A. Abdallah, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4270-4270
Open Access | Times Cited: 14
Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 14
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, Molecular insights, and Structure-activity relationship
Nimmagadda Venkata Satya Sai Aishwarya, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139655-139655
Closed Access | Times Cited: 4
Exploring the Antiproliferative Potential of Morpholine‐Functionalized Aurones: Design, Synthesis, SAR, DFT, Hirshfeld Surface, 3D Energy Frameworks and Molecular Docking Analysis
Gourav Kumar, Bhavna Saroha, Bavita Kumari, et al.
ChemistrySelect (2024) Vol. 9, Iss. 20
Closed Access | Times Cited: 3
1,2,3-Triazole Derivatives with Anti-breast Cancer Potential
Xinyi Wu, Jun Wang, Shiqi Xia, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 1406-1425
Closed Access | Times Cited: 20
Design, synthesis of 1,2,4-triazine derivatives as antidepressant and antioxidant agents: In vitro, in vivo and in silico studies
Rohit Pal, Bhupinder Kumar, Guruubasavaraja Swamy P M, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106284-106284
Closed Access | Times Cited: 18
Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase
Ghanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 3, pp. 1582-1614
Closed Access | Times Cited: 8
An updated literature on BRAF inhibitors (2018–2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2689-2730
Closed Access | Times Cited: 7
Current Developments in the Pyran-Based Analogues as Anticancer Agents
Parul Grover, Monika Bhardwaj, Lovekesh Mehta, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 19, pp. 3239-3268
Closed Access | Times Cited: 16
One‐Pot Multicomponent Synthesis of Novel Spiro‐(1,8)‐Naphthyridine Derivatives in PEG‐400
Fatemeh Asilpour, Dariush Saberi, Alireza Hasaninejad
ChemistrySelect (2023) Vol. 8, Iss. 39
Closed Access | Times Cited: 5
Synthesis and biological research of new imidazolone-sulphonamide-pyrimidine hybrids as potential EGFR-TK inhibitors and apoptosis-inducing agents
Dalal Nasser Binjawhar, Hanadi A. Katouah, Najla A. Alshaye, et al.
RSC Advances (2024) Vol. 14, Iss. 28, pp. 20120-20129
Open Access | Times Cited: 1
Synthesis of N-alkyl azoles carrying metal complexes for catalytic and medicinal applications
Rimsha Kanwal, Muhammad Adnan Iqbal, Adina Zafar, et al.
Inorganic Chemistry Communications (2024), pp. 113144-113144
Closed Access | Times Cited: 1
Synthesis of Mono- and Polyazole Hybrids Based on Polyfluoroflavones
Mariya A. Panova, Константин В. Щербаков, Ekaterina F. Zhilina, et al.
Molecules (2023) Vol. 28, Iss. 2, pp. 869-869
Open Access | Times Cited: 4
Recent Updates on the Anticancer Activity of Quinoxaline Hybrids (Jan. 2017-Jan. 2022)
Lian‐Shun Feng, Chuan Gao, Fa-Wu Liu, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 1426-1441
Closed Access | Times Cited: 5
Identification of Potent CHK2 Inhibitors‐Modulators for Therapeutic Application in Cancer: A Machine Learning Integrated Fragment‐Based Drug Design Approach
Mahima Sudhir Kolpe, Vikramsinh Sardarsinh Suryawanshi, Gaber E. Eldesoky, et al.
ChemistrySelect (2024) Vol. 9, Iss. 39
Closed Access
Dibenzoxanthene-β-Lactam Hybrids as Potential Antioxidant and Anticancer Agents: Synthesis, Biological Evaluation, and Docking Study
Somayeh Ranjbari, Aliasghar Jarrahpour, Roghayeh Heiran, et al.
Journal of Molecular Structure (2024), pp. 140455-140455
Closed Access
Design, Synthesis, and Biological Evaluation of 2-Butyl-4-Chloroimidazole-Derived 1,3,4-Oxadiazoles: ACE Inhibition, Anticancer, and Antitubercular Activities
R. Manjunath, Preethi G. Anantharaju, Subbarao V Madhunapantulas, et al.
Journal of Molecular Structure (2024) Vol. 1322, pp. 140630-140630
Open Access
Design of novel 4-maleimidylphenyl-hydrazide molecules displaying anti-inflammatory properties: Refining the chemical structure
Francis Cloutier, Yassine Oufqir, Laurie Fortin, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 5, pp. 100064-100064
Open Access | Times Cited: 1
Page 1

Scroll to top